Search - tctmd.com

Displaying 521 - 540 of 602

Sort: Relevancy | Date

Presentation TCT 2012

TCT-10. Efficacy of Renal Denervation is Positively Impacted by Longitudinal Treatments

Presenter: Meital Mazor

October 23, 2012

Presentation TCT 2012

State-of-the-Field Keynote: The Next Challenge: Improving Technical Efficiency and Biological Response (Nonresponders)

Presenter: Deepak Bhatt

October 23, 2012

Presentation TCT 2012

Preclinical Review: Perirenal Nerve Distribution, Density, and Quantification: Implications for the Evaluation of Device Safety and Efficacy

Presenter: Renu Virmani

October 23, 2012

Presentation TCT 2012

Hypertension: Renal Denervation

Presenter: Deepak Bhatt

October 23, 2012

Presentation TCT 2012

Essentials of Renal Artery Disease: Guidelines, Assessment, and Outcomes

Presenter: Jeffrey Olin

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(5)

Presenter: Paul Sobotka

October 23, 2012

News Industry News

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

October 22, 2012

Presentation TCT 2012

Treating Fibromuscular Dysplasia in the Renal Artery

Presenter: Robert Lookstein

October 22, 2012

Presentation TCT 2012

Selecting the Patient Most Likely to Benefit from Renal Intervention

Presenter: Massoud Leesar

October 22, 2012

Presentation TCT 2012

Role of Renal Revascularization in 2012 and Predictions for the Future

Presenter: Michael Jaff

October 22, 2012

Presentation TCT 2012

Renal Sympathetic Denervation for HTN

Presenter: Lynne Hinterbuchner

October 22, 2012

Presentation TCT 2012

Management of Mesenteric Arteries in EVAR

Presenter: Jacques Busquet

October 22, 2012

Presentation TCT 2012

Endovascular Approaches to Acute and Chronic Mesenteric Ischemia

Presenter: Adam Geronemus

October 22, 2012

Presentation TCT 2012

Diagnosis and Technical Management of Renal and Visceral Aneurysms

Presenter: Ripal Gandhi

October 22, 2012

Presentation TCT 2012

DES for Vascular Erectile Dysfunction: Follow-up from the ZEN First-in-Man Study

Presenter: Krishna Rocha-Singh

October 22, 2012

Presentation TCT 2012

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro!

Presenter: Mehdi Shishehbor

October 22, 2012

Presentation TCT 2012

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Con!

Presenter: Christopher White

October 22, 2012

Presentation TCT 2012

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Pro!

Presenter: Michel Henry

October 22, 2012

Presentation TCT 2012

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Con!

Presenter: Christopher Cooper

October 22, 2012

Presentation TCT 2012

Avoiding Complications in Renal Artery Stenting: Lessons from a Master

Presenter: Mark Bates

October 22, 2012

Advertisement

TCT-10. Efficacy of Renal Denervation is Positively Impacted by Longitudinal Treatments

State-of-the-Field Keynote: The Next Challenge: Improving Technical Efficiency and Biological Response (Nonresponders)

Preclinical Review: Perirenal Nerve Distribution, Density, and Quantification: Implications for the Evaluation of Device Safety and Efficacy

Hypertension: Renal Denervation

Essentials of Renal Artery Disease: Guidelines, Assessment, and Outcomes

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(5)

Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT

Treating Fibromuscular Dysplasia in the Renal Artery

Selecting the Patient Most Likely to Benefit from Renal Intervention

Role of Renal Revascularization in 2012 and Predictions for the Future

Renal Sympathetic Denervation for HTN

Management of Mesenteric Arteries in EVAR

Endovascular Approaches to Acute and Chronic Mesenteric Ischemia

Diagnosis and Technical Management of Renal and Visceral Aneurysms

DES for Vascular Erectile Dysfunction: Follow-up from the ZEN First-in-Man Study

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Pro!

Debate II. Should Renal Artery Stenting Only Be Done Using FFR and IVUS? Con!

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Pro!

Debate I. Is Embolic Protection Mandatory in Renal Artery Stenting? Con!

Avoiding Complications in Renal Artery Stenting: Lessons from a Master

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content